Premium
Bulk drugs firm Supriya Lifescience Ltd, which was being courted by private equity firms last year, now feels going public is better, two people in the know told VCCircle. The initial public offering’s (IPO) size is expected to be Rs 1,250 crore ($172.5 million), one of the persons said. Last year, VCCircle ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
